News
Study evaluates novel small molecule TNF-alpha inhibitor as potential alternative to biologic treatments TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback